Therefore, we determined the expression levels of eIF4E and its most well-established regulatory proteins 4E-BP1, 4E-BP2 and p4E-BP1 within tumour cells of a large cohort of cancer patients, and have combined these data into an improved measure of prognosis and estimate of eIF4E activity. This evidence concerns the gene EIF4EBP1 and cancer.